FDA Inspection 1323352 — Paul S. Bradley, MD

Paul S. Bradley, MD — FEI 3012259395

The FDA completed an inspection of Paul S. Bradley, MD on Jun 11, 2026 in Savannah, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 11, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Savannah, GA (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.